Dr Reddy's Recalls 13,560 Bottles Of Toprol XL Generic From U.S. Market
This article was originally published in PharmAsia News
The U.S. FDA said Dr Reddy's Laboratories has recalled 13,560 bottles of its generic version of AstraZeneca's Toprol XL (metoprotol) extended-release drug for treating high blood pressure after it failed a dissolution test.
You may also be interested in...
The company said its own calculations suggest a mid-November readout could yield a positive result, keeping it on track for an EUA before the end of 2020.
With COVID-19 continuing to wreak havoc in the EU just as throughout the globe, the European Commission is proposing new measures that will impact antigen test availability and use
Amgen’s management took a deep dive into biosimilar market dynamics during the company’s third-quarter earnings call, as the California-based biotech continued to enjoy success for biosimilars in the US and Europe.